Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
One of the leading industrial gas producers and suppliers, Praxair Inc. ( PX - Analyst Report ) recently announced the opening of a new air separation plant, the third of its kind, in Colombia.
The plant with a daily producing capacity of 200 tons of oxygen, nitrogen and argon is located 50 km from Bogota in the free trade zone of Gran Sabana. The industrial gases produced will be supplied to Brazilian steelmaker, Gerdau S.A.’s ( GGB - Analyst Report ) plant in Colombia. Apart from this, the plant will also take care of the requirements of the local oil and gas, manufacturing, chemicals, food and beverage and medical industry.
Of late, Praxair started a number of air separation plants including two in China. One was started in Nanjing, Jiangsu province for Meishan Iron and Steel Co., Ltd while another in Wuwei, Anhui province, for coal based chemicals project of Anhui HuaYi Chemical Co., Ltd.
A series of plant start-ups and contract wins signifies the growing preferences among customers for Praxair’s world class technology, high quality products and gas supply services.
The current Zacks Consensus Estimate for the second quarter of 2012 is $1.42, representing a year-over-year increase of 3.07%. Estimates for the fiscal years 2012 and 2013 are $5.79 and $6.59, reflecting annual growth of 6.54% and 13.85%, respectively.
Praxair is slated to release its second quarter 2012 financial results on July 25, while its prime competitor, Air Products & Chemicals Inc. ( APD - Analyst Report ) is expected to declare its third quarter results on July 24, 2012.
We maintain a Neutral recommendation on Praxair. The stock also carries a Zacks #4 Rank, implying a short-term (1-3 months) Sell rating.
Read the full Analyst Report on GGB
Read the full Analyst Report on PX
Read the full Analyst Report on APD